Connection

Stephen Ethier to Cell Line, Tumor

This is a "connection" page, showing publications Stephen Ethier has written about Cell Line, Tumor.
Connection Strength

1.673
  1. Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer. PLoS One. 2019; 14(11):e0224420.
    View in: PubMed
    Score: 0.122
  2. Functional oncogene signatures guide rationally designed combination therapies to synergistically induce breast cancer cell death. Oncotarget. 2016 Jun 14; 7(24):36138-36153.
    View in: PubMed
    Score: 0.096
  3. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERa in SUM-44 breast cancer cells and is associated with ERa over-expression in breast cancer. Mol Oncol. 2016 06; 10(6):850-65.
    View in: PubMed
    Score: 0.094
  4. Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes. Exp Cell Res. 2015 Mar 15; 332(2):223-35.
    View in: PubMed
    Score: 0.088
  5. Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancer. Mol Oncol. 2015 Feb; 9(2):527-43.
    View in: PubMed
    Score: 0.086
  6. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia. 2014 Aug; 16(8):644-55.
    View in: PubMed
    Score: 0.085
  7. Knock-down of amphiregulin inhibits cellular invasion in inflammatory breast cancer. J Cell Physiol. 2011 Oct; 226(10):2691-701.
    View in: PubMed
    Score: 0.069
  8. Transforming properties of 8p11-12 amplified genes in human breast cancer. Cancer Res. 2010 Nov 01; 70(21):8487-97.
    View in: PubMed
    Score: 0.065
  9. HER-2 signaling, acquisition of growth factor independence, and regulation of biological networks associated with cell transformation. Cancer Res. 2010 Oct 15; 70(20):7862-73.
    View in: PubMed
    Score: 0.064
  10. Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers. Int J Cancer. 2009 Oct 01; 125(7):1613-21.
    View in: PubMed
    Score: 0.060
  11. Transforming properties of TC-1 in human breast cancer: interaction with FGFR2 and beta-catenin signaling pathways. Int J Cancer. 2007 Sep 15; 121(6):1265-73.
    View in: PubMed
    Score: 0.052
  12. Differential signal transduction of alternatively spliced FGFR2 variants expressed in human mammary epithelial cells. J Cell Physiol. 2007 Mar; 210(3):720-31.
    View in: PubMed
    Score: 0.051
  13. Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Cancer Res. 2006 Dec 15; 66(24):11632-43.
    View in: PubMed
    Score: 0.050
  14. Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells. J Biol Chem. 2006 Dec 08; 281(49):37728-37.
    View in: PubMed
    Score: 0.049
  15. Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon. Oncogene. 2007 Mar 29; 26(14):2104-14.
    View in: PubMed
    Score: 0.049
  16. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells. Oncogene. 2005 Apr 28; 24(19):3177-86.
    View in: PubMed
    Score: 0.045
  17. Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines. Cancer Genet Cytogenet. 2004 Nov; 155(1):57-62.
    View in: PubMed
    Score: 0.043
  18. Chromosomal instability and lack of cyclin E regulation in hCdc4 mutant human breast cancer cells. Breast Cancer Res. 2004; 6(5):R531-9.
    View in: PubMed
    Score: 0.042
  19. p38MAPK induces cell surface alpha4 integrin downregulation to facilitate erbB-2-mediated invasion. Neoplasia. 2003 Mar-Apr; 5(2):128-34.
    View in: PubMed
    Score: 0.038
  20. Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers. Nat Commun. 2016 10 11; 7:13050.
    View in: PubMed
    Score: 0.025
  21. MYC Is a Crucial Mediator of TGF?-Induced Invasion in Basal Breast Cancer. Cancer Res. 2016 06 15; 76(12):3520-30.
    View in: PubMed
    Score: 0.024
  22. Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer. Breast Cancer Res. 2015 Sep 22; 17:130.
    View in: PubMed
    Score: 0.023
  23. Reproducibility: changing the policies and culture of cell line authentication. Nat Methods. 2015 Jun; 12(6):493-7.
    View in: PubMed
    Score: 0.022
  24. SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression. Mol Cancer Ther. 2014 Nov; 13(11):2713-26.
    View in: PubMed
    Score: 0.021
  25. Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell. 2013 Oct 14; 24(4):450-65.
    View in: PubMed
    Score: 0.020
  26. Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes. Mol Oncol. 2012 Oct; 6(5):494-506.
    View in: PubMed
    Score: 0.018
  27. ERLIN2 promotes breast cancer cell survival by modulating endoplasmic reticulum stress pathways. BMC Cancer. 2012 Jun 08; 12:225.
    View in: PubMed
    Score: 0.018
  28. Induction of proapoptotic antibodies to triple-negative breast cancer by vaccination with TRAIL death receptor DR5 DNA. Int J Cancer. 2012 Dec 01; 131(11):2562-72.
    View in: PubMed
    Score: 0.018
  29. Identification and functional analysis of 9p24 amplified genes in human breast cancer. Oncogene. 2012 Jan 19; 31(3):333-41.
    View in: PubMed
    Score: 0.017
  30. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res. 2011 Feb 15; 71(4):1292-301.
    View in: PubMed
    Score: 0.017
  31. Disulfiram treatment facilitates phosphoinositide 3-kinase inhibition in human breast cancer cells in vitro and in vivo. Cancer Res. 2010 May 15; 70(10):3996-4004.
    View in: PubMed
    Score: 0.016
  32. Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Res Treat. 2010 May; 121(1):53-64.
    View in: PubMed
    Score: 0.015
  33. Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot study. Cancer Res. 2008 Dec 15; 68(24):10045-50.
    View in: PubMed
    Score: 0.014
  34. Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines. Breast Cancer Res Treat. 2009 Jan; 113(2):285-91.
    View in: PubMed
    Score: 0.014
  35. Comprehensive analysis of oncogenic effects of PIK3CA mutations in human mammary epithelial cells. Breast Cancer Res Treat. 2008 Nov; 112(2):217-27.
    View in: PubMed
    Score: 0.013
  36. Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet. 2008 Jan; 40(1):102-7.
    View in: PubMed
    Score: 0.013
  37. p38MAPK-activated AKT in HER-2 overexpressing human breast cancer cells acts as an EGF-independent survival signal. J Surg Res. 2007 Sep; 142(1):162-9.
    View in: PubMed
    Score: 0.013
  38. LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer. Cancer Res. 2007 May 01; 67(9):4123-9.
    View in: PubMed
    Score: 0.013
  39. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006 Dec; 10(6):515-27.
    View in: PubMed
    Score: 0.012
  40. Differential phosphoprotein mapping in cancer cells using protein microarrays produced from 2-D liquid fractionation. Anal Chem. 2006 Feb 01; 78(3):702-10.
    View in: PubMed
    Score: 0.012
  41. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Res. 2006 Jan 01; 66(1):41-5.
    View in: PubMed
    Score: 0.012
  42. Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol Cancer Res. 2005 Dec; 3(12):655-67.
    View in: PubMed
    Score: 0.012
  43. Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells. Cancer Res. 2004 Dec 01; 64(23):8674-81.
    View in: PubMed
    Score: 0.011
  44. Cleavage of beta-catenin by calpain in prostate and mammary tumor cells. Cancer Res. 2004 Oct 15; 64(20):7237-40.
    View in: PubMed
    Score: 0.011
  45. Stat3 modulates heat shock 27kDa protein expression in breast epithelial cells. Biochem Biophys Res Commun. 2004 Jan 30; 314(1):143-50.
    View in: PubMed
    Score: 0.010
  46. Radiosensitization by pan ErbB inhibitor CI-1033 in vitro and in vivo. Clin Cancer Res. 2004 Jan 15; 10(2):691-700.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.